InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,626.02
(
0.54%
)
US TECH 100
18,986.40
(
0.30%
)
Dow Jones
41,393.78
(
0.72%
)
Brent Oil
71.83
(
0.00%
)
Bitcoin
59,967.63
(
-1.01%
)
Post# of 334
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

K-G

Send PM Follow Ignore
Followers 4
Posts 153
Boards Moderated 0
Alias Born 10/25/2006

K-G

Re: None

Friday, 02/23/2007 11:30:55 AM

Friday, February 23, 2007 11:30:55 AM

Post# of 334
gfp,
Have you looked at Anadys Pharmaceuticals? They have had trouble over the years - recently with their Hepatitis C treatment and a change in CEO. Yesterday they had higher than expected losses, and PPS is down today. Even though they have gone through several name changes, they seem to be well run and have a variety of compounds they are advancing, and have a seemingly good partnership with Novartis. Situations like this can go either way, but it may mean there is an investment opportunity. Any thoughts?
Thanks.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up